Skip to content

Effects of Sleep Deprivation on Blood Hormones and Inflammatory Status After Exercise Induced-muscle Damage

Effects of Sleep Deprivation on Blood Hormones and Inflammatory Status After Exercise Induced-muscle Damage

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02082600
Enrollment
10
Registered
2014-03-10
Start date
2013-07-31
Completion date
Unknown
Last updated
2014-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep, Sleep Deprivation

Brief summary

The aims of this study are examine the effects of sleep deprivation in muscle recovery after a maximum eccentric resistance exercise session performed on an isokinetic dynamometer (24 series of 10 repetitions). The sample will consist of 10 men, sedentary, clinically healthy, aged between 20 and 31 years old. Two experimental groups will be developed: EXE-SLEEP, in which subjects will perform the exercise protocol (\ 18:00-19:00) and will be subject to normal period of sleep for 3 nights; EXE-TOTAL, in which subjects will perform the same exercise protocol and will be sleep deprived for 60 hours, followed by one night of sleep rebound.

Detailed description

The blood parameters analyzed will be: * Creatine kinase and myoglobin: before, immediately after, 2, 4, 12, 24, 36, 48, and 60 hours after exercise protocol. * Total and free testosterone, IGF-1, and cortisol: before, immediately after, 2, 4, 12, 24, 36, 48, and 60 hours after exercise protocol. Moreover, from 19:00 of the second day to 19:00 of the third day it will be collected blood samples every 2 hours. * GH: during the second night, GH will be evaluated every 1 hour, from 23:00 to 07:00. * TNF-alfa, IL-6, IL-1 beta, IL-10, and IL-1ra: before, immediately after, and 2 hour after exercise, as well every 4 hours from 19:00 of the second day to 19:00 of the third day. It will be evaluated isometric strength every 12 hours, as well visual analog scale of pain.

Interventions

OTHERSleep deprivation

This group will perform 24 sets of 10 maximum repetitions of eccentric contractions for quadriceps and than will keep awake for 60 hours (2 nights), followed by 1 night of sleep, all inside the lab. During whole protocol, it will be collected several blood samples for evaluation of hormones, cytokines and muscle damage parameters. It will be also evaluated isometric strength and pain.

This group will perform 24 sets of 10 maximum repetitions of eccentric contractions for quadriceps and and will be able to sleep the 3 nights. During whole protocol, it will be collected several blood samples for evaluation of hormones, cytokines and muscle damage parameters. It will be also evaluated isometric strength and pain.

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 31 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy subjects * sedentary * sleep duration between 6-8 hours peer night

Exclusion criteria

* smokers * use vitamin supplements, like C and E * drink two doses of alcohol/day or \> 4 doses in one occasion * use of anti-inflammatory drugs * antilipidemic drugs * anemia * muscle or joint diseases * cardiovascular diseases * diabetes * renal diseases * sleep disturbances * breathing disorders

Design outcomes

Primary

MeasureTime frame
Change from baseline in isometric strengthBefore exercise, immediatly after, 12, 24, 36, 48, and 60 hours after exercise induced-muscle damage

Secondary

MeasureTime frame
Area Under Curve for serum total and free testosterone, IGF-1, and cortisolBlood samples will be collected every 2 hours, for 24 hours.

Other

MeasureTime frame
Area Under Curve for serum pro and anti-inflammatory cytokinesBlood samples will be collected every 4 hours, for 24 hours.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026